Microbial translocation is a cause of systemic immune activation in chronic HIV infection - PubMed (original) (raw)
. 2006 Dec;12(12):1365-71.
doi: 10.1038/nm1511. Epub 2006 Nov 19.
David A Price, Timothy W Schacker, Tedi E Asher, Guido Silvestri, Srinivas Rao, Zachary Kazzaz, Ethan Bornstein, Olivier Lambotte, Daniel Altmann, Bruce R Blazar, Benigno Rodriguez, Leia Teixeira-Johnson, Alan Landay, Jeffrey N Martin, Frederick M Hecht, Louis J Picker, Michael M Lederman, Steven G Deeks, Daniel C Douek
Affiliations
- PMID: 17115046
- DOI: 10.1038/nm1511
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M Brenchley et al. Nat Med. 2006 Dec.
Abstract
Chronic activation of the immune system is a hallmark of progressive HIV infection and better predicts disease outcome than plasma viral load, yet its etiology remains obscure. Here we show that circulating microbial products, probably derived from the gastrointestinal tract, are a cause of HIV-related systemic immune activation. Circulating lipopolysaccharide, which we used as an indicator of microbial translocation, was significantly increased in chronically HIV-infected individuals and in simian immunodeficiency virus (SIV)-infected rhesus macaques (P <or= 0.002). We show that increased lipopolysaccharide is bioactive in vivo and correlates with measures of innate and adaptive immune activation. Effective antiretroviral therapy seemed to reduce microbial translocation partially. Furthermore, in nonpathogenic SIV infection of sooty mangabeys, microbial translocation did not seem to occur. These data establish a mechanism for chronic immune activation in the context of a compromised gastrointestinal mucosal surface and provide new directions for therapeutic interventions that modify the consequences of acute HIV infection.
Comment in
- Gut microbes out of control in HIV infection.
Haynes BF. Haynes BF. Nat Med. 2006 Dec;12(12):1351-2. doi: 10.1038/nm1206-1351. Nat Med. 2006. PMID: 17151687 No abstract available.
Similar articles
- Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.
Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M, Barclay GR, Smedley J, Pung R, Oliveira KM, Hirsch VM, Silvestri G, Douek DC, Miller CJ, Haase AT, Lifson J, Brenchley JM. Estes JD, et al. PLoS Pathog. 2010 Aug 19;6(8):e1001052. doi: 10.1371/journal.ppat.1001052. PLoS Pathog. 2010. PMID: 20808901 Free PMC article. - Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.
Moniuszko M, Liyanage NP, Doster MN, Parks RW, Grubczak K, Lipinska D, McKinnon K, Brown C, Hirsch V, Vaccari M, Gordon S, Pegu P, Fenizia C, Flisiak R, Grzeszczuk A, Dabrowska M, Robert-Guroff M, Silvestri G, Stevenson M, McCune J, Franchini G. Moniuszko M, et al. AIDS Res Hum Retroviruses. 2015 Jan;31(1):115-26. doi: 10.1089/AID.2013.0220. AIDS Res Hum Retroviruses. 2015. PMID: 24432835 Free PMC article. - Simian immunodeficiency virus-induced alterations in monocyte production of tumor necrosis factor alpha contribute to reduced immune activation in sooty mangabeys.
Mir KD, Bosinger SE, Gasper M, Ho O, Else JG, Brenchley JM, Kelvin DJ, Silvestri G, Hu SL, Sodora DL. Mir KD, et al. J Virol. 2012 Jul;86(14):7605-15. doi: 10.1128/JVI.06813-11. Epub 2012 May 2. J Virol. 2012. PMID: 22553338 Free PMC article. - Microbial translocation in the pathogenesis of HIV infection and AIDS.
Marchetti G, Tincati C, Silvestri G. Marchetti G, et al. Clin Microbiol Rev. 2013 Jan;26(1):2-18. doi: 10.1128/CMR.00050-12. Clin Microbiol Rev. 2013. PMID: 23297256 Free PMC article. Review. - Th17 cells, HIV and the gut mucosal barrier.
Dandekar S, George MD, Bäumler AJ. Dandekar S, et al. Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3. Curr Opin HIV AIDS. 2010. PMID: 20543596 Review.
Cited by
- Interaction between endogenous bacterial flora and latent HIV infection.
Victoriano AF, Imai K, Okamoto T. Victoriano AF, et al. Clin Vaccine Immunol. 2013 Jun;20(6):773-9. doi: 10.1128/CVI.00766-12. Epub 2013 Apr 24. Clin Vaccine Immunol. 2013. PMID: 23616411 Free PMC article. Review. - I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections.
Pandrea I, Brooks K, Desai RP, Tare M, Brenchley JM, Apetrei C. Pandrea I, et al. Front Immunol. 2022 Aug 12;13:899559. doi: 10.3389/fimmu.2022.899559. eCollection 2022. Front Immunol. 2022. PMID: 36032119 Free PMC article. Review. - Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial.
Baker JV, Huppler Hullsiek K, Prosser R, Duprez D, Grimm R, Tracy RP, Rhame F, Henry K, Neaton JD. Baker JV, et al. PLoS One. 2012;7(10):e46894. doi: 10.1371/journal.pone.0046894. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082133 Free PMC article. Clinical Trial. - Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia.
Liu Z, Wang W, Luo J, Zhang Y, Zhang Y, Gan Z, Shen X, Zhang Y, Meng X. Liu Z, et al. Front Pharmacol. 2021 Apr 21;12:531325. doi: 10.3389/fphar.2021.531325. eCollection 2021. Front Pharmacol. 2021. PMID: 33967742 Free PMC article. Review. - Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
Aberg JA, Tebas P, Overton ET, Gupta SK, Sax PE, Landay A, Falcon R, Ryan R, De La Rosa G. Aberg JA, et al. AIDS Res Hum Retroviruses. 2012 Oct;28(10):1184-95. doi: 10.1089/aid.2011.0327. Epub 2012 Apr 2. AIDS Res Hum Retroviruses. 2012. PMID: 22352336 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
- AI 25879/AI/NIAID NIH HHS/United States
- AI41531/AI/NIAID NIH HHS/United States
- RR-00165/RR/NCRR NIH HHS/United States
- G108/441/MRC_/Medical Research Council/United Kingdom
- AI 36219/AI/NIAID NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- AI066998/AI/NIAID NIH HHS/United States
- M01-RR0083-37/RR/NCRR NIH HHS/United States
- R0I AI052755/AI/NIAID NIH HHS/United States
- P30 AI27763/AI/NIAID NIH HHS/United States
- AI052745/AI/NIAID NIH HHS/United States
- P30 MH62246/MH/NIMH NIH HHS/United States
- AI 38858/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical